Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Alx Oncology Holdings (ALXO) Other Operating Expenses (2019 - 2020)

Alx Oncology Holdings' Other Operating Expenses history spans 2 years, with the latest figure at $479000.0 for Q2 2020.

  • For Q2 2020, Other Operating Expenses fell 90.03% year-over-year to $479000.0; the TTM value through Mar 2021 reached $479000.0, down 94.53%, while the annual FY2025 figure was $3.2 million, N/A changed from the prior year.
  • Other Operating Expenses for Q2 2020 was $479000.0 at Alx Oncology Holdings, down from $596000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $4.8 million in Q2 2019 and bottomed at $479000.0 in Q2 2020.